Hispanic/Latino American males and females generally have lower cancer rates than the total population. However, health gaps still exist within certain types of cancer.1
From 2019-2023, both Hispanic/Latino males and females died from stomach cancer at a rate that exceeded their peers from the total population by 54% and 85%, respectively.2
In 2022:
- Hispanic/Latino males were 40% less frequently diagnosed with oral cavity and pharynx cancer than males from the total population.
- Hispanic/Latino females had similar diagnosis rates for pancreatic cancer as the total female population.
Visit MedlinePlus for more health information about Cancer and Living with Cancer in Spanish.
Visit the Centers for Disease Control and Prevention and the National Cancer Institute for information about cancer screening.
Looking for curated searches on cancer within minority and tribal populations, including Hispanic/Latino populations, in the United States and its territories? Check out the OMH Knowledge Center Topic Guides.
Occurrence
| Cancer among adults ages 18 and over, age-adjusted percentage, 2024 | |||
|---|---|---|---|
| Cancer | Hispanic | Total Population | Ratio (Hispanic / Total) |
| All Sites | 3.9 | 10.3 | 0.38 |
| Breast | 0.8 | 1.8 | 0.44 |
| Cervical (Female) | 0.4 | 0.7 | 0.57 |
| Prostate (Males) | 0.9 | 2.6 | 0.35 |
| Any Skin | 0.4 | 3.6 | 0.11 |
Top Cancer Sites
| Cancer incidence among males, delay-adjusted and age-adjusted rate per 100,000 population, 2022 | |||
|---|---|---|---|
| Cancer | Hispanic Males | Total Population Males | Ratio (Hispanic / Total) |
| All Sites | 392.7 | 500.3 | 0.78 |
| Colon & Rectum (Including Appendix) | 42.1 | 43.5 | 0.97 |
| Esophagus | 4.9 | 7.3 | 0.67 |
| Kidney | 25.6 | 23.6 | 1.08 |
| Liver & Intrahepatic Bile Duct (IBD) | 21.0 | 13.9 | 1.51 |
| Lung | 29.7 | 51.0 | 0.58 |
| Oral Cavity & Pharynx | 10.7 | 17.9 | 0.60 |
| Pancreas | 14.1 | 15.9 | 0.89 |
| Prostate | 102.4 | 133.6 | 0.77 |
| Stomach | 12.4 | 9.6 | 1.29 |
| Cancer incidence among females, delay-adjusted and age-adjusted rate per 100,000 population, 2022 | |||
|---|---|---|---|
| Cancer | Hispanic Female | Total Population Female | Ratio (Hispanic / Total) |
| All Sites | 389.5 | 441.7 | 0.88 |
| Breast | 114.1 | 136.5 | 0.84 |
| Cervical | 10.4 | 7.8 | 1.33 |
| Colon & Rectum (Including Appendix) | 31.7 | 34.0 | 0.93 |
| Kidney | 14.8 | 12.0 | 1.23 |
| Liver & Intrahepatic Bile Duct (IBD) | 10.0 | 5.8 | 1.72 |
| Lung | 24.2 | 43.7 | 0.55 |
| Pancreas | 12.8 | 12.7 | 1.01 |
| Stomach | 9.7 | 6.5 | 1.49 |
| Uterus | 30.0 | 29.2 | 1.03 |
Five-Year Survival Rates
| 5-year survival rate among males, percentage, 2015–2021 | |||
|---|---|---|---|
| Cancer | Hispanic Males | Total Population Male | Ratio (Hispanic / Total) |
| All Sites | 64.1 | 68.7 | 0.93 |
| Colon & Rectum (Including Appendix) | 62.8 | 64.5 | 0.97 |
| Kidney | 76.1 | 78.8 | 0.97 |
| Liver & IBD | 20.4 | 21.7 | 0.94 |
| Lung | 20.8 | 23.8 | 0.87 |
| Pancreas | 12.7 | 13.1 | 0.97 |
| Prostate | 94.2 | 97.9 | 0.96 |
| Stomach | 30.2 | 34.2 | 0.88 |
| 5-year survival rate among females, percentage, 2015-2021 | |||
|---|---|---|---|
| Cancer | Hispanic | Total Population | Ratio (Hispanic / Total) |
| All Sites | 70.9 | 71.2 | 1.00 |
| Breast | 89.0 | 91.7 | 0.97 |
| Cervical | 70.5 | 68.0 | 1.04 |
| Colon & Rectum (Including Appendix) | 66.8 | 66.4 | 1.01 |
| Kidney | 82.3 | 81.4 | 1.01 |
| Liver & IBD | 21.9 | 22.8 | 0.96 |
| Lung | 32.7 | 32.6 | 1.00 |
| Pancreas | 16.0 | 13.5 | 1.19 |
| Stomach | 38.1 | 43.2 | 0.88 |
| Uterus | 80.5 | 81.1 | 0.99 |
Mortality
| 5-year mortality among males, age-adjusted rate per 100,000 population, 2019–2023 | |||
|---|---|---|---|
| Cancer | Hispanic Males | Total Population Males | Ratio (Hispanic / Total) |
| All Sites | 124.4 | 171.5 | 0.73 |
| Colon & Rectum (Including Appendix) | 13.2 | 15.3 | 0.86 |
| Liver & IBD | 12.2 | 9.4 | 1.30 |
| Lung | 18.7 | 37.2 | 0.50 |
| Pancreas | 9.6 | 12.9 | 0.74 |
| Prostate | 15.4 | 19.2 | 0.80 |
| Stomach | 5.4 | 3.5 | 1.54 |
| 5-year mortality among females, age-adjusted rate per 100,000 population, 2019–2023 | |||
|---|---|---|---|
| Cancer | Hispanic Female | Total Population Female | Ratio (Hispanic / Total) |
| All Sites | 93.2 | 126.3 | 0.74 |
| Breast | 13.6 | 19.2 | 0.71 |
| Cervical | 2.3 | 2.2 | 1.05 |
| Colon & Rectum (Including Appendix) | 8.6 | 10.8 | 0.80 |
| Liver & IBD | 6.1 | 4.3 | 1.42 |
| Pancreas | 8.2 | 9.9 | 0.83 |
| Stomach | 3.7 | 2.0 | 1.85 |
| Uterus | 4.5 | 5.3 | 0.85 |
Health Care Use
| Females ages 40 and over who had a mammogram within the past 2 years, crude percentage, 2019 | |||
|---|---|---|---|
| Hispanic Female | Total Population Female | Ratio (Hispanic / Total) | |
| 69.4 | 79.8 | 0.87 | |
| Females aged 21 to 65 years receiving a cervical cancer screening based on the most recent guidelines, percentage, 2021 | |||
|---|---|---|---|
| Hispanic Female | Total Population Female | Ratio (Hispanic / Total) | |
| 67.4 | 73.9 | 0.91 | |
| Adults aged 45 to 75 years receiving a colorectal cancer screening based on the most recent guidelines, percentage, 2023 | |||
|---|---|---|---|
| Hispanic | Total Population | Ratio (Hispanic / Total) | |
| 54.1 | 63.5 | 0.85 | |
1 SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16 [Accessed 6/24/2025]. https://seer.cancer.gov/statistics-network/explorer/ (Back to top)
2 SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16 [Accessed 6/24/2025]. https://seer.cancer.gov/statistics-network/explorer/ (Back to top)
Date Last Reviewed: January 2026
